Skinvisible (SKVI) Short Interest Ratio & Short Volume

Short interest is the volume of Skinvisible shares that have been sold short but have not yet been closed out or covered. As of June 30th, investors have sold 100 shares of SKVI short. Learn More on Skinvisible's current short interest.

Skinvisible saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 100 shares, a decline of 85.7% from the previous total of 700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Skinvisible: Aytu BioPharma, Inc. (2.00%), Genprex, Inc. (5.43%), Coeptis Therapeutics Holdings, Inc. (0.93%), Viracta Therapeutics, Inc. (5.66%), Mustang Bio, Inc. (0.58%), Eagle Pharmaceuticals, Inc. (2.90%), iBio, Inc. (2.22%), Ensysce Biosciences, Inc. (8.83%), Addex Therapeutics Ltd (1.87%), Conduit Pharmaceuticals Inc. (1.51%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks.

Short selling SKVI is an investing strategy that aims to generate trading profit from Skinvisible as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Skinvisible occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SKVI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SKVI, twice per month. The most recent reporting period available is June, 30 2024.